New therapeutic targets for endometriosis predicted through mendelian randomization analysis and case-control trials
These results suggest that <i>RSPO3</i> may be a new target for the treatment of endometriosis, providing a direction for future drug development.
Authors
- Xiaotong Wang (ORCID: https://orcid.org/0000-0002-6509-7734)
- Ran Cui (ORCID: https://orcid.org/0000-0003-4386-3140)
- Guangmei Zhang (ORCID: https://orcid.org/0000-0003-0211-5111)
- Baoju Wang (ORCID: https://orcid.org/0000-0003-1403-4749)
- Yue Yin
- Linyao Zheng
Institutions
- Harbin Medical University (CN)
- Second Affiliated Hospital of Harbin Medical University (CN)
- First Affiliated Hospital of Harbin Medical University (CN)
Publication Details
- Journal
- Frontiers in Genetics
- Published
- 2025-08-15
- DOI
- https://doi.org/10.3389/fgene.2025.1631446
- Primary Topic
- Endometriosis Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Key Research and Development Program of Heilongjiang
- National Natural Science Foundation of China